Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Ранг среди акций #12697
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Цена акции
$2.04
Рыночная капитализация
$122.58M
Изменение (1 день)
4.48%
Изменение (1 год)
-1.05%
Страна
FR
Торговля Crossject Société Anonyme (ALCJ)

Категория

Коэффициент P/S для Crossject Société Anonyme (ALCJ)
Коэффициент P/S на July 2026 TTM: 71.80
Согласно последним финансовым отчетам и цене акций Crossject Société Anonyme, текущий коэффициент P/S (TTM) составляет 71.80. В конце 2023 он составлял 1.26K.
История P/S для Crossject Société Anonyme с 2010 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
2026 (TTM) 71.80 194.15%
2024 24.41 -98.06%
2023 1.26K 911.76%
2022 124.63 55.54%
2021 80.13 434.26%
2020 15.00 -83.59%
2019 91.39 1,279.32%
2018 6.63 -47.30%
2017 12.57 -44.75%
2016 22.76 -47.42%
2015 43.28 8.99%
2014 39.71 -21.42%
2013 50.54 -54.97%
2012 112.23 83.88%
2011 61.03 -69.23%
2010 198.36 0.00%
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
13.31 -81.46%
US
2.65 -96.31%
FR
4.46 -93.79%
DE
9.16 -87.24%
JP
2.57 -96.43%
US